A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...
Cytotheryx, a growing biotech firm working on treatments for liver disease, recently paid a combined $7.6 million to buy the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results